Suppr超能文献

人乳头瘤病毒E6和E7:宫颈癌的标志及治疗靶点

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy.

作者信息

Pal Asmita, Kundu Rita

机构信息

Cell Biology Laboratory, Department of Botany, Centre of Advanced Studies, University of Calcutta, Kolkata, India.

出版信息

Front Microbiol. 2020 Jan 21;10:3116. doi: 10.3389/fmicb.2019.03116. eCollection 2019.

Abstract

Human papillomavirus (HPV)-induced cervical cancer is a major health issue among women from the poorly/under-developed sectors of the world. It accounts for a high-mortality rate because of its late diagnosis and poor prognosis. Initial establishment and subsequent progression of this form of cancer are completely dependent on two major oncogenes E6 and E7, which are expressed constitutively leading to tumorigenesis. Thus, manipulation of these genes represents the most successful form of cervical cancer therapy. In the present article, information on structural, functional, and clinical dimensions of E6 and E7 activity has been reviewed. The genome organization and protein structure of E6 and E7 have been discussed followed by their mechanism to establish the six major cancer hallmarks in cervical tissues for tumor propagation. The later section of this review article deals with the different modes of therapeutics, which functions by deregulating E6 and E7 activity. Since E6 and E7 are the biomarkers of a cervical cancer cell and are the ones driving the cancer progression, therapeutic approaches targeting E6 and E7 have been proved to be highly efficient in terms of focused removal of abnormally propagating malignant cells. Therapeutics including different forms of vaccines to advanced genome editing techniques, which suppress E6 and E7 activity, have been found to successfully bring down the population of cervical cancer cells infected with HPV. T-cell mediated immunotherapy is another upcoming successful form of treatment to eradicate HPV-infected tumorigenic cells. Additionally, therapeutics using natural compounds from plants or other natural repositories, i.e., phytotherapeutic approaches have also been reviewed here, which prove their anticancer potential through E6 and E7 inhibitory effects. Thus, E6 and E7 repression through any of these methods is a significant approach toward cervical cancer therapy, described in details in this review along with an insight into the signaling pathways and molecular mechanistic of E6 and E7 action.

摘要

人乳头瘤病毒(HPV)引发的宫颈癌是世界贫困/欠发达地区女性面临的一个重大健康问题。由于其诊断较晚且预后较差,导致死亡率很高。这种癌症的初始形成及后续进展完全依赖于两个主要癌基因E6和E7,它们持续表达从而导致肿瘤发生。因此,操控这些基因是宫颈癌治疗最成功的方式。在本文中,我们综述了有关E6和E7活性的结构、功能及临床方面的信息。讨论了E6和E7的基因组结构和蛋白质结构,随后阐述了它们在宫颈组织中确立六大癌症特征以促进肿瘤增殖的机制。本文综述的后半部分涉及不同的治疗方式,这些方式通过调节E6和E7的活性发挥作用。由于E6和E7是宫颈癌细胞的生物标志物且是驱动癌症进展的因素,事实证明,针对E6和E7的治疗方法在靶向清除异常增殖的恶性细胞方面非常有效。已发现包括从不同形式的疫苗到先进的基因组编辑技术等多种治疗方法,均可抑制E6和E7的活性,从而成功减少感染HPV的宫颈癌细胞数量。T细胞介导的免疫疗法是另一种即将取得成功的治疗方式,可根除感染HPV的致瘤细胞。此外,本文还综述了使用植物或其他天然来源的天然化合物的治疗方法,即植物治疗方法,这些方法通过抑制E6和E7的作用证明了其抗癌潜力。因此,通过上述任何一种方法抑制E6和E7是宫颈癌治疗的重要途径,本文将详细描述这一途径,并深入探讨E6和E7作用的信号通路及分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/443c/6985034/7cff2f416b2e/fmicb-10-03116-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验